HVJ-E
AXP000130.1 · Oncolytic virus
- Platform
- Sendai virus envelope (UV-inactivated, non-replicating)
- Originator
- Osaka University (Yasufumi Kaneda)
- Sponsor
- GenomIdea
Names
Virus
- Role
- Other
- Family
- Paramyxoviridae
- Virus
- Sendai virus (NCBI Taxonomy 3052731)
- Strain
- HVJ (Z strain lineage), UV-inactivated envelope
- Replication
- non replicating
- Modifications
- UV-inactivated virions; genome replication-incompetent, envelope fusion retained
- Route
- intratumoral
- Source
- evidence
Approvals
No regulatory approval recorded.
Clinical trials (2)
| Trial | Title | Status | Phase | Start | Primary completion | Enrolment | Conditions |
|---|---|---|---|---|---|---|---|
| NCT03818893 | Combination Therapy With GEN0101 and Pembrolizmub in Advanced Melanoma Patients PIb/PII | Unknown | Phase 2 | 2019-03 | 2021-12-31 | 46 | Advanced Melanoma |
| NCT02502994 | Phase 1 Study of GEN0101 in Patients With Recurrence of CRPC | Unknown | Phase 1 | 2015-05 | 2016-12 | 12 | Castration Resistant Prostate Cancer |
Recent changes
No changes recorded in its trials yet.
Clinical papers
| PubMed | Title | Journal | Year | Linked by |
|---|---|---|---|---|
| PMID 39358654 | Dose-escalation, tolerability, and efficacy of intratumoral and subcutaneous injection of hemagglutinating virus of Japan envelope (HVJ-E) against chemotherapy-resistant malignant pleural mesothelioma: a clinical trial. | Cancer immunology, immunotherapy : CII | 2024 | name in title: HVJ-E |
| PMID 34984539 | A phase I dose-escalation, safety/tolerability, and preliminary efficacy study of the intratumoral administration of GEN0101 in patients with advanced melanoma. | Cancer immunology, immunotherapy : CII | 2022 | name in title: GEN0101 |
| PMID 32112659 | Intratumoral and s.c. injection of inactivated hemagglutinating virus of Japan envelope (GEN0101) in metastatic castration-resistant prostate cancer. | Cancer science | 2020 | name in title: GEN0101 |
| PMID 28497777 | Phase I/II clinical trial to assess safety and efficacy of intratumoral and subcutaneous injection of HVJ-E in castration-resistant prostate cancer patients. | Cancer gene therapy | 2017 | name in title: HVJ-E |
Unconfirmed matches (1)
Found by a weaker match (an ambiguous or short name, or a name only in the abstract); not counted. Corrections welcome.
| PubMed | Title | Journal | Year | Linked by |
|---|---|---|---|---|
| PMID 32047956 | Intratumoral injection of hemagglutinating virus of Japan-envelope vector yielded an antitumor effect for advanced melanoma: a phase I/IIa clinical study. | Cancer immunology, immunotherapy : CII | 2020 | name in abstract: HVJ-E |
Other papers
Preclinical studies, reviews and other papers that name it, newest 100 shown.
| PubMed | Title | Journal | Year | Linked by |
|---|---|---|---|---|
| PMID 42423067 | Exploring the potential of HVJ-E for cancer immunotherapy. | Immunotherapy | 2026 | name in title: HVJ-E |
| PMID 40541272 | HVJ-E links Apolipoprotein d to antitumor effects. | Journal for immunotherapy of cancer | 2025 | name in title: HVJ-E |
| PMID 38215278 | The press-assisted fusion scheme significantly mitigates the quantity of HVJ-E required in mitochondrial replacement techniques. | Reproduction (Cambridge, England) | 2024 | name in title: HVJ-E |
| PMID 39534532 | Local treatment of HVJ-E with T cell costimulatory molecule stimulation elicits systemic anti-tumor effects. | Molecular therapy. Oncology | 2024 | name in title: HVJ-E |
| PMID 33575480 | CXCL2 combined with HVJ-E suppresses tumor growth and lung metastasis in breast cancer and enhances anti-PD-1 antibody therapy. | Molecular therapy oncolytics | 2021 | name in title: HVJ-E |
| PMID 31492206 | A Novel Cellular Imaging Method Using Hemagglutinating Virus of Japan-Envelope (HVJ-E) Vector and Magnetic Particle Imaging. | Journal of nanoscience and nanotechnology | 2020 | name in title: HVJ-E |
| PMID 32705650 | Hemagglutinating Virus of Japan Envelope (HVJ-E)-Guided Gene Transfer to the Intestinal Epithelium. | Methods in molecular biology (Clifton, N.J.) | 2020 | name in title: HVJ-E |
| PMID 30956733 | Boron-incorporating hemagglutinating virus of Japan envelope (HVJ-E) nanomaterial in boron neutron capture therapy. | Science and technology of advanced materials | 2019 | name in title: HVJ-E |
| PMID 30534001 | ERK-mediated autophagy promotes inactivated Sendai virus (HVJ-E)-induced apoptosis in HeLa cells in an Atg3-dependent manner. | Cancer cell international | 2018 | name in title: HVJ-E |
| PMID 26553555 | A biomimetic approach to hormone resistant prostate cancer cell isolation using inactivated Sendai virus (HVJ-E). | Biomaterials science | 2016 | name in title: HVJ-E |
| PMID 28787810 | Inactivated Sendai Virus (HVJ-E) Immobilized Electrospun Nanofiber for Cancer Therapy. | Materials (Basel, Switzerland) | 2015 | name in title: HVJ-E |
| PMID 23441859 | Nano-decoration of the Hemagglutinating Virus of Japan envelope (HVJ-E) using a layer-by-layer assembly technique. | Langmuir : the ACS journal of surfaces and colloids | 2013 | name in title: HVJ-E |
| PMID 21900962 | The combination of chemotherapy with HVJ-E containing Rad51 siRNA elicited diverse anti-tumor effects and synergistically suppressed melanoma. | Gene therapy | 2012 | name in title: HVJ-E |
| PMID 22727893 | HVJ-E/importin-β hybrid vector for overcoming cytoplasmic and nuclear membranes as double barrier for non-viral gene delivery. | Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie | 2012 | name in title: HVJ-E |
| PMID 20730616 | Immunogene therapy using immunomodulating HVJ-E vector augments anti-tumor effects in murine malignant glioma. | Journal of neuro-oncology | 2011 | name in title: HVJ-E |
| PMID 21444118 | Immunoadjuvant effects of hemagglutinating virus of Japan envelope (HVJ-E) on the inactivated H9 subtype avian influenza virus vaccine. | Veterinary immunology and immunopathology | 2011 | name in title: HVJ-E |
| PMID 21982767 | Hemagglutinating virus of Japan envelope (HVJ-E) can enhance the immune responses of swine immunized with killed PRRSV vaccine. | Biochemical and biophysical research communications | 2011 | name in title: HVJ-E |
| PMID 19830690 | Sterile alpha motif containing domain 9 is involved in death signaling of malignant glioma treated with inactivated Sendai virus particle (HVJ-E) or type I interferon. | International journal of cancer | 2010 | name in title: HVJ-E |
| PMID 20338150 | Reprogramming of somatic cells induced by fusion of embryonic stem cells using hemagglutinating virus of Japan envelope (HVJ-E). | Biochemical and biophysical research communications | 2010 | name in title: HVJ-E |
| PMID 21053301 | Efficient in vivo delivery of plasmids and oligonucleotides using hemagglutinating virus of Japan envelope (HVJ-E) vector in immunological disease models. | Current protocols in immunology | 2010 | name in title: HVJ-E |
| PMID 17072578 | Needleless intranasal administration of HVJ-E containing allergen attenuates experimental allergic rhinitis. | Journal of molecular medicine (Berlin, Germany) | 2007 | name in title: HVJ-E |
| PMID 17352194 | [GenomONE HVJ-E vector]. | Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme | 2007 | name in title: HVJ-E |
| PMID 17883878 | A new therapy for highly effective tumor eradication using HVJ-E combined with chemotherapy. | BMC medicine | 2007 | name in title: HVJ-E |
| PMID 17961511 | Development of a transferrin receptor-targeting HVJ-E vector. | Biochemical and biophysical research communications | 2007 | name in title: HVJ-E |
| PMID 16177820 | Liver-directed gene therapy of diabetic rats using an HVJ-E vector containing EBV plasmids expressing insulin and GLUT 2 transporter. | Gene therapy | 2006 | name in title: HVJ-E |
| PMID 16134237 | Magnetic nanoparticles with surface modification enhanced gene delivery of HVJ-E vector. | Biochemical and biophysical research communications | 2005 | name in title: HVJ-E |
| PMID 14630698 | Intrathecal injection of HVJ-E containing HGF gene to cerebrospinal fluid can prevent and ameliorate hearing impairment in rats. | FASEB journal : official publication of the Federation of American Societies for Experimental Biology | 2004 | name in title: HVJ-E |
Unconfirmed matches (73)
Found by a weaker match (an ambiguous or short name, or a name only in the abstract); not counted. Corrections welcome.
| PubMed | Title | Journal | Year | Linked by |
|---|---|---|---|---|
| PMID 40690186 | Hemagglutinating virus of Japan envelope encapsulating microRNA-34a-5p robustly induces apoptosis of malignant meningioma cells by suppressing survivin. | Journal of neuro-oncology | 2025 | name in abstract: HVJ-E |
| PMID 36765886 | Add-On Effect of Hemagglutinating Virus of Japan Envelope Combined with Chemotherapy or Immune Checkpoint Inhibitor against Malignant Pleural Mesothelioma: An In Vivo Study. | Cancers | 2023 | name in abstract: HVJ-E |
| PMID 36564568 | DNA barcoding and gene expression recording reveal the presence of cancer cells with unique properties during tumor progression. | Cellular and molecular life sciences : CMLS | 2022 | name in abstract: HVJ-E |
| PMID 36671464 | An In Vivo Screening Model for Investigation of Pathophysiology of Human Implantation Failure. | Biomolecules | 2022 | name in abstract: HVJ-E |
| PMID 32592133 | Efficient photodynamic therapy against drug-resistant prostate cancer using replication-deficient virus particles and talaporfin sodium. | Lasers in medical science | 2021 | name in abstract: HVJ-E |
| PMID 33155337 | Hemagglutinating virus of Japan-envelope containing programmed cell death-ligand 1 siRNA inhibits immunosuppressive activities and elicits antitumor immune responses in glioma. | Cancer science | 2021 | name in abstract: HVJ-E |
| PMID 31383952 | Cancer immunotherapy using the Fusion gene of Sendai virus. | Cancer gene therapy | 2020 | name in abstract: HVJ-E |
| PMID 30191468 | Inhibition of Neointima Hyperplasia, Inflammation, and Reactive Oxygen Species in Balloon-Injured Arteries by HVJ Envelope Vector-Mediated Delivery of Superoxide Dismutase Gene. | Translational stroke research | 2019 | name in abstract: HVJ-E |
| PMID 32255916 | Photodynamic therapy by lysosomal-targeted drug delivery using talaporfin sodium incorporated into inactivated virus particles. | Laser therapy | 2019 | name in abstract: HVJ-E |
| PMID 29757287 | Combinational Treatment of Trichostatin A and Vitamin C Improves the Efficiency of Cloning Mice by Somatic Cell Nuclear Transfer. | Journal of visualized experiments : JoVE | 2018 | name in abstract: HVJ-E |
| PMID 29773091 | Inactivated Sendai Virus Induces ROS-dependent Apoptosis and Autophagy in Human Prostate Cancer Cells. | Biomedical and environmental sciences : BES | 2018 | name in abstract: HVJ-E |
| PMID 27960629 | Preclinical study and clinical trial of a novel therapeutic vaccine against multi-drug resistant tuberculosis. | Human vaccines & immunotherapeutics | 2017 | name in abstract: HVJ-E |
| PMID 28456782 | Salmonella mediated the hemagglutinating virus of Japan-envelope transfer suppresses tumor growth. | Oncotarget | 2017 | name in abstract: HVJ-E |
| PMID 28587331 | Directly reprogramming fibroblasts into adipogenic, neurogenic and hepatogenic differentiation lineages by defined factors. | Experimental and therapeutic medicine | 2017 | name in abstract: HVJ-E |
| PMID 28945328 | Inactivated Sendai virus particle upregulates cancer cell expression of intercellular adhesion molecule-1 and enhances natural killer cell sensitivity on cancer cells. | Cancer science | 2017 | name in abstract: HVJ-E |
| PMID 29079353 | Photodynamic therapy using a cytotoxic photosensitizer porphyrus envelope that targets the cell membrane. | Photodiagnosis and photodynamic therapy | 2017 | name in abstract: HVJ-E |
| PMID 26548591 | An RNA Molecule Derived From Sendai Virus DI Particles Induces Antitumor Immunity and Cancer Cell-selective Apoptosis. | Molecular therapy : the journal of the American Society of Gene Therapy | 2016 | name in abstract: HVJ-E |
| PMID 27141155 | Effective photodynamic therapy in drug-resistant prostate cancer cells utilizing a non-viral antitumor vector (a secondary publication). | Laser therapy | 2016 | name in abstract: HVJ-E |
| PMID 27145280 | Cytoplasmic calcium increase via fusion with inactivated Sendai virus induces apoptosis in human multiple myeloma cells by downregulation of c-Myc oncogene. | Oncotarget | 2016 | name in abstract: HVJ-E |
| PMID 27259252 | Virus-stimulated neutrophils in the tumor microenvironment enhance T cell-mediated anti-tumor immunity. | Oncotarget | 2016 | name in abstract: HVJ-E |
| PMID 28081748 | Inactivated Sendai virus induces apoptosis mediated by reactive oxygen species in murine melanoma cells. | Biomedical and environmental sciences : BES | 2016 | name in abstract: HVJ-E |
| PMID 25315678 | Effective capture of proteins inside living cells by antibodies indirectly linked to a novel cell-penetrating polymer-modified protein A derivative. | The FEBS journal | 2015 | name in abstract: HVJ-E |
| PMID 25952096 | Effects of ROCK inhibitor Y-27632 on cell fusion through a microslit. | Biotechnology and bioengineering | 2015 | name in abstract: HVJ-E |
| PMID 26131319 | New model for cardiomyocyte sheet transplantation using a virus-cell fusion technique. | World journal of stem cells | 2015 | name in abstract: HVJ-E |
| PMID 26235873 | Inactivated Sendai virus induces apoptosis and autophagy via the PI3K/Akt/mTOR/p70S6K pathway in human non-small cell lung cancer cells. | Biochemical and biophysical research communications | 2015 | name in abstract: HVJ-E |
| PMID 23784981 | IPS-1 plays a dual function to directly induce apoptosis in murine melanoma cells by inactivated Sendai virus. | International journal of cancer | 2014 | name in abstract: HVJ-E |
| PMID 24371227 | Accumulation of cytosolic calcium induces necroptotic cell death in human neuroblastoma. | Cancer research | 2014 | name in abstract: HVJ-E |
| PMID 24629697 | A novel photodynamic therapy for drug-resistant prostate cancer cells using porphyrus envelope as a novel photosensitizer. | Photodiagnosis and photodynamic therapy | 2014 | name in abstract: HVJ-E |
| PMID 25023327 | Systemic administration of platelets incorporating inactivated Sendai virus eradicates melanoma in mice. | Molecular therapy : the journal of the American Society of Gene Therapy | 2014 | name in abstract: HVJ-E |
| PMID 25073909 | Induction of apoptosis in hormone-resistant human prostate cancer PC3 cells by inactivated Sendai virus. | Biomedical and environmental sciences : BES | 2014 | name in abstract: HVJ-E |
| PMID 23134437 | 13-Cis retinoic acid can enhance the antitumor activity of non-replicating Sendai virus particle against neuroblastoma. | Cancer science | 2013 | name in abstract: HVJ-E |
| PMID 23249543 | The study of novel DNA vaccines against tuberculosis: induction of pathogen-specific CTL in the mouse and monkey models of tuberculosis. | Human vaccines & immunotherapeutics | 2013 | name in abstract: HVJ-E |
| PMID 23251005 | Systemic administration of a novel immune-stimulatory pseudovirion suppresses lung metastatic melanoma by regionally enhancing IFN-γ production. | Clinical cancer research : an official journal of the American Association for Cancer Research | 2013 | name in abstract: HVJ-E |
| PMID 23734313 | The RIG-I/MAVS signaling pathway in cancer cell-selective apoptosis. | Oncoimmunology | 2013 | name in abstract: HVJ-E |
| PMID 23886549 | Anti-tumor effects of inactivated Sendai virus particles with an IL-2 gene on angiosarcoma. | Clinical immunology (Orlando, Fla.) | 2013 | name in abstract: HVJ-E |
| PMID 24157924 | Recent advances and developments in the antitumor effect of the HVJ envelope vector on malignant melanoma: from the bench to clinical application. | Cancer gene therapy | 2013 | name in abstract: HVJ-E |
| PMID 21443915 | Virosome: a novel vector to enable multi-modal strategies for cancer therapy. | Advanced drug delivery reviews | 2012 | name in abstract: HVJ-E |
| PMID 22894526 | In vitro investigation of efficient photodynamic therapy using a nonviral vector; hemagglutinating virus of Japan envelope. | Journal of biomedical optics | 2012 | name in abstract: HVJ-E |
| PMID 23014529 | TRAIL and Noxa are selectively upregulated in prostate cancer cells downstream of the RIG-I/MAVS signaling pathway by nonreplicating Sendai virus particles. | Clinical cancer research : an official journal of the American Association for Cancer Research | 2012 | name in abstract: HVJ-E |
| PMID 23066541 | In vitro investigation of efficient photodynamic therapy using a nonviral vector; hemagglutinating virus of Japan envelope. | Journal of biomedical optics | 2012 | name in abstract: HVJ-E |
| PMID 23085849 | In vitro investigation of efficient photodynamic therapy using a nonviral vector; hemagglutinating virus of Japan envelope. | Journal of biomedical optics | 2012 | name in abstract: HVJ-E |
| PMID 23122307 | Inactivated Sendai virus suppresses murine melanoma growth by inducing host immune responses and down-regulating β-catenin expression. | Biomedical and environmental sciences : BES | 2012 | name in abstract: HVJ-E |
| PMID 21247507 | Cationized gelatin-HVJ envelope with sodium borocaptate improved the BNCT efficacy for liver tumors in vivo. | Radiation oncology (London, England) | 2011 | name in abstract: HVJ-E |
| PMID 21546794 | Novel therapeutic vaccine: granulysin and new DNA vaccine against Tuberculosis. | Human vaccines | 2011 | name in abstract: HVJ-E |
| PMID 21958872 | Knockdown of the tachykinin neurokinin 1 receptor by intrathecal administration of small interfering RNA in rats. | European journal of pharmacology | 2011 | name in abstract: HVJ-E |
| PMID 21189152 | A non-replicating oncolytic vector as a novel therapeutic tool against cancer. | BMB reports | 2010 | name in abstract: HVJ-E |
| PMID 19173282 | Efficient eradication of hormone-resistant human prostate cancers by inactivated Sendai virus particle. | International journal of cancer | 2009 | name in abstract: HVJ-E |
| PMID 19424601 | A comparison of non-viral vectors for gene delivery to pancreatic beta-cells: delivering a hypoxia-inducible vascular endothelial growth factor gene to rat islets. | International journal of molecular medicine | 2009 | name in abstract: HVJ-E |
| PMID 19578737 | Anti-tumor effects of fusion cells of type 1 dendritic cells and Meth A tumor cells using hemagglutinating virus of Japan-envelope. | International journal of oncology | 2009 | name in abstract: HVJ-E |
| PMID 19675593 | Highly efficient eradication of intracranial glioblastoma using Eg5 siRNA combined with HVJ envelope. | Gene therapy | 2009 | name in abstract: HVJ-E |
| PMID 17602226 | Intratumoral injection of inactivated Sendai virus particles elicits strong antitumor activity by enhancing local CXCL10 expression and systemic NK cell activation. | Cancer immunology, immunotherapy : CII | 2008 | name in abstract: HVJ-E |
| PMID 17653716 | New potential therapy for orthotopic bladder carcinoma by combining HVJ envelope with doxorubicin. | Cancer chemotherapy and pharmacology | 2008 | name in abstract: HVJ-E |
| PMID 18221753 | Efficient delivery of antibody into living cells using a novel HVJ envelope vector system. | Journal of immunological methods | 2008 | name in abstract: HVJ-E |
| PMID 18248320 | Applications of Hemagglutinating Virus of Japan in therapeutic delivery systems. | Expert opinion on drug delivery | 2008 | name in abstract: HVJ-E |
| PMID 18358837 | Sendai virus F glycoprotein induces IL-6 production in dendritic cells in a fusion-independent manner. | FEBS letters | 2008 | name in abstract: HVJ-E |
| PMID 18813894 | Percutaneous nonviral delivery of hepatocyte growth factor in an osteotomy gap promotes bone repair in rabbits: a preliminary study. | Clinical orthopaedics and related research | 2008 | name in abstract: HVJ-E |
| PMID 17149789 | Rapid transport of plasmid DNA into the nucleolus via actin depolymerization using the HVJ envelope vector. | The journal of gene medicine | 2007 | name in abstract: HVJ-E |
| PMID 17210703 | Inactivated Sendai virus particles eradicate tumors by inducing immune responses through blocking regulatory T cells. | Cancer research | 2007 | name in abstract: HVJ-E |
| PMID 17316929 | Immunisation of male mice with a plasmid DNA vaccine encoding gonadotrophin releasing hormone (GnRH-I) and T-helper epitopes suppresses fertility in vivo. | Vaccine | 2007 | name in abstract: HVJ-E |
| PMID 17377741 | Preparation and evaluation of gene-transfected cultured skin as a novel drug delivery system for severely burned skin. | Pharmaceutical research | 2007 | name in abstract: HVJ-E |
| PMID 17892442 | Development of tissue-targeting hemagglutinating virus of Japan envelope vector for successful delivery of therapeutic gene to mouse skin. | Human gene therapy | 2007 | name in abstract: HVJ-E |
| PMID 18040151 | [Anticancer immunotherapy using inactivated Sendai virus particles]. | Uirusu | 2007 | name in abstract: HVJ-E |
| PMID 16488483 | Simple and highly efficient method for transient in vivo gene transfer to mid-late pregnant mouse uterus. | Journal of reproductive immunology | 2006 | name in abstract: HVJ-E |
| PMID 16610935 | Development of high-throughput functional screening of therapeutic genes, using a hemagglutinating virus of Japan envelope vector. | Human gene therapy | 2006 | name in abstract: HVJ-E |
| PMID 16648574 | Targeted chemotherapy against intraperitoneally disseminated colon carcinoma using a cationized gelatin-conjugated HVJ envelope vector. | Molecular cancer therapeutics | 2006 | name in abstract: HVJ-E |
| PMID 17048546 | Novel drug delivery system by surface modified magnetic nanoparticles. | Journal of nanoscience and nanotechnology | 2006 | name in abstract: HVJ-E |
| PMID 17075769 | Transient local overexpression of human vascular endothelial growth factor (VEGF) in mouse feto-maternal interface during mid-term pregnancy lowers systemic maternal blood pressure. | Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme | 2006 | name in abstract: HVJ-E |
| PMID 17083992 | Enhancement of gene transfer activity mediated by mannosylated dendrimer/alpha-cyclodextrin conjugate (generation 3, G3). | Journal of controlled release : official journal of the Controlled Release Society | 2006 | name in abstract: HVJ-E |
| PMID 15712245 | Biocompatible polymer enhances the in vitro and in vivo transfection efficiency of HVJ envelope vector. | The journal of gene medicine | 2005 | name in abstract: HVJ-E |
| PMID 15763165 | Direct in vivo protein transduction into a specific restricted brain area in rats. | Neuroscience letters | 2005 | name in abstract: HVJ-E |
| PMID 16111768 | In vivo gene transfer into the mouse uterus: a powerful tool for investigating implantation physiology. | Journal of reproductive immunology | 2005 | name in abstract: HVJ-E |
| PMID 17281548 | A viral envelope as a vehicle for tracer, drug, and gene delivery: initial biodistribution study using PET imaging. | Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference | 2005 | name in abstract: HVJ-E |
| PMID 17282303 | A Viral Envelope as a Vehicle for Tracer, Drug, and Gene Delivery: Initial Biodistribution Study Using PET Imaging. | Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference | 2005 | name in abstract: HVJ-E |
NIH grants
No confirmed grants yet.
Unconfirmed matches (1)
Found by a weaker match (an ambiguous or short name, or a name only in the abstract); not counted. Corrections welcome.
| Project | Title | Organisation | PI | Years | Linked by |
|---|---|---|---|---|---|
| ZIAAI000432 | Regulation Of Immune Responses In Humans and in Experimental Animals | NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES | STROBER, WARREN | 2011–2011 | name in abstract: HVJ-E |
Notes
Hemagglutinating virus of Japan envelope: inactivated, replication-incompetent Sendai virus particles given intratumorally, development code GEN0101. Included because it is a virus particle therapy dosed as an intratumoral anti-tumour agent, but it does not replicate, so the owner may prefer to exclude it from an oncolytic census.
How to cite
HVJ-E (AXP000130.1). The Abstractinator program registry, release 2026-11-17+2c46e992acfc. https://abstractinator.me/registry/AXP000130.html
Something wrong or missing? Suggest a correction (a GitHub issue; please link your evidence). Entry created 2026-11-11, updated 2026-11-11.